Neuroimaging schizophrenia: A picture is worth a thousand words, but is it saying anything important?

Current Psychiatry Reports

Volumn 15, Issue 3, 2013, Pages

  Ahmed, Anthony O ^a   Buckley, Peter F ^a   Hanna, Mona ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Clinical course; Endophenotype; Functional; Imaging; Neurocognition; Neuroimaging; Neuropathology; Outcome; Psychiatry; Psychosis; Schizophrenia; Structural; Symptoms; Treatment

Indexed keywords

BRAIN; HUMAN; METHODOLOGY; NEUROIMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGICAL ASPECT; REVIEW; SCHIZOPHRENIA;

BRAIN; HUMANS; NEUROIMAGING; PREDICTIVE VALUE OF TESTS; SCHIZOPHRENIA;

MLCS; MLOWN;

EID: 84878456284     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-012-0345-0     Document Type: Article

References (96)

1. Johnstone E, Frith CD, Crow TJ, et al. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet. 1976;308(7992):924-6.
2. Olabi B, Ellison-Wright I, Bullmore E, Lawrie SM. Structural brain changes in first episode Schizophrenia compared with Fronto-Temporal Lobar Degeneration: a meta-analysis. BMC Psychiatry. 2012;12(1):104.
3. Tang J, Liao Y, Zhou B, et al. Decrease in temporal gyrus gray matter volume in first-episode, early onset schizophrenia: an MRI study. PLoS One. 2012;7(7):e40247.
4. Simper R, Walker MA, Black G, et al. The relationship between callosal axons and cortical neurons in the planum temporale: alterations in schizophrenia. Neurosci Res. 2011;71(4):405-10.
5. Smiley JF, Rosoklija G, Mancevski B, et al. Hemispheric comparisons of neuron density in the planum temporale of schizophrenia and nonpsychiatric brains. Psychiatry Res. 2011;192(1):1-11.
6. Shen Y-C, Tsai H-M, Ruan J-W, et al. Genetic and functional analyses of the gene encoding synaptophysin in schizophrenia. Schizophr Res. 2012;137(1-3):14-9.
7. Glausier JR, Lewis DA.: Dendritic spine pathology in schizophrenia. Neuroscience 2012, In Press.
8. Garey L. When cortical development goes wrong: schizophrenia as a neurodevelopmental disease of microcircuits. J Ant. 2010;217 (4):324-33.
9. Achim AM, Lepage M. Episodic memory-related activation in schizophrenia: meta-analysis. Br J Psychiatry. 2005;187:500-9. (Pubitemid 41752738)
10. Li H, Chan RCK, McAlonan GM, Gong Q. Facial emotion processing in schizophrenia: a meta-analysis of functional neuroimaging data. Schizophr Bull. 2010;36(5):1029-39.
11. Volpe U, Mucci A, Quarantelli M, et al. Dorsolateral prefrontal cortex volume in patients with deficit or nondeficit schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2012;37(2):264-9.
12. Galderisi S, Quarantelli M, Volpe U, et al. Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia. Schizophr Bull. 2008;34(2):393-401. (Pubitemid 351323325)
13. Bora E, Fornito A, Radua J, et al. Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and metaregression analysis. Schizophr Res. 2011;127(1-3):46-57.
14. Honea R, Crow TJ, Passingham D, Mackay CE. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry. 2005;162(12):2233-45. (Pubitemid 41740200)
15. Hao Y, Yan Q, Liu H, et al. Schizophrenia patients and their healthy siblings share disruption of white matter integrity in the left prefrontal cortex and the hippocampus but not the anterior cingulate cortex. Schizophr Res. 2009;114(1-3):128-35.
16. Yang Y, Fung SJ, Rothwell A, et al. Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia. Biol Psychiatry. 2011;69(1):63-70.
17. Joshi D, Fung SJ, Rothwell A, Weickert CS. Higher gammaaminobutyric Acid neuron density in the white matter of orbital frontal cortex in schizophrenia. Biol Psychiatry. 2012;72(9):725-33.
18. Minzenberg MJ, Laird AR, Thelen S, et al. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry. 2009;66(8):811-22.
19. Ragland JD, Laird AR, Ranganath C, et al. Prefrontal activation deficits during episodic memory in schizophrenia. Am J Psychiatry. 2009;166(8):863-74.
20. Kumra S, Robinson P, Tambyraja R, et al. Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. J Am Acad Child Adolesc Psychiatry. 2012;51(2):171-80.
21. Zhou S-Y, Suzuki M, Takahashi T, et al. Parietal lobe volume deficits in schizophrenia spectrum disorders. Schizophr Res. 2007;89(1-3):35-48. (Pubitemid 44881293)
22. Lee K-H, Farrow TFD, Parks RW, et al. Increased cerebellar vermis white-matter volume in men with schizophrenia. J Psychiatr Res. 2007;41(8):645-51. (Pubitemid 46498103)
23. Picard H, Amado I, Mouchet-Mages S, et al. The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophr Bull. 2008;34(1):155-72. (Pubitemid 350262281)
24. Lawyer G, Nesvag R, Varnäs K, et al. Grey and white matter proportional relationships in the cerebellar vermis altered in schizophrenia. Cerebellum. 2009;8(1):52-60.
25. Cronenwett WJ, Csernansky J. Thalamic pathology in schizophrenia. Curr Top Behav Neurosci. 2010;4:509-28.
26. Glenthoj A, Glenthoj BY, Mackeprang T, et al. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res. 2007;154(3):199-208. (Pubitemid 46428524)
27. Guller Y, Ferrarelli F, Shackman AJ, et al. Probing thalamic integrity in schizophrenia using concurrent transcranial magnetic stimulation and functional magnetic resonance imaging. Arch Gen Psychiatry. 2012;69(7):662-71.
28. Welsh RC, Chen AC, Taylor SF. Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in schizophrenia. Schizophr Bull. 2010;36(4):713-22.
29. Pettersson-Yeo W, Allen P, Benetti S, et al. Dysconnectivity in schizophrenia: Where are we now? Neurosci Biobehav Rev. 2011;35(5):1110-24.
30. Buckley PF. Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implications. Neuropsychiatr Dis Treat. 2005;1(3):193-204.
31. Whalley HC, Papmeyer M, Sprooten E, et al. Review of functional magnetic resonance imaging studies comparing bipolar disorder and schizophrenia. Bipolar Disord. 2012;14(4):411-31.
32. Gottesman II, Shields J. Genetic Theorizing and Schizophrenia. BJP. 1973;122(566):15-30.
33. Gottesman II, Gould TD. The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions. Am J Psychiatry. 2003;160(4):636-45. (Pubitemid 41079594)
34. Pillai A, Buckley PF. Reliable biomarkers and predictors of schizophrenia and its treatment. Psychiatr Clin North Am. 2012;35(3):645-59.
35. Rose EJ, Donohoe G.: Brain vs Behavior: An Effect Size Comparison of Neuroimaging and Cognitive Studies of Genetic Risk for Schizophrenia. Schizophr Bull. 2012;Apr 12 [Epub ahead of print].
36. Harms MP, Wang L, Campanella C, et al. Structural abnormalities in gyri of the prefrontal cortex in individuals with schizophrenia and their unaffected siblings. Br J Psychiatry. 2010;196(2):150-7.
37. Rosso IM, Makris N, Thermenos HW, et al. Regional prefrontal cortex gray matter volumes in youth at familial risk for schizophrenia from the Harvard Adolescent High Risk Study. Schizophr Res. 2010;123(1):15-21.
38. Lawrie SM, McIntosh AM, Hall J, et al. Brain Structure and Function Changes During the Development of Schizophrenia: The Evidence From Studies of Subjects at Increased Genetic Risk. Schizophr Bull. 2008;34(2):330-40. (Pubitemid 351323338)
39. Bohner G, Milakara D, Witthaus H, et al. MTR abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls. Schizophr Res. 2012;137(1-3):85-90. 40
40. Bhojraj TS, Francis AN, Rajarethinam R, et al. Verbal fluency deficits and altered lateralization of language brain areas in individuals genetically predisposed to schizophrenia. Schizophr Res. 2009;115(2-3):202-8.
41. MacDonald AW, Thermenos HW, Barch DM, Seidman LJ. Imaging Genetic Liability to Schizophrenia: Systematic Review of fMRI Studies of Patients' Nonpsychotic Relatives. Schizophr Bull. 2009;35(6):1142-62.
42. Witthaus H, Mendes U, Brüne M, et al. Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia. J Psychiatry Neurosci. 2010;35(1):33-40.
43. Mechelli A, Riecher-Rössler A, Meisenzahl EM, et al. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch Gen Psychiatry. 2011;68(5):489-95.
44. Dazzan P, Soulsby B, Mechelli A, et al. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. Schizophr Bull. 2012;38(5):1083-91.
45. Job DE, Whalley HC, McIntosh AM, et al. Grey matter changes can improve the prediction of schizophrenia in subjects at high risk. BMC Med. 2006;4:29.
46. Job DE, Whalley HC, Johnstone EC, Lawrie SM. Grey matter changes over time in high risk subjects developing schizophrenia. NeuroImage. 2005;25(4):1023-30. (Pubitemid 40591646)
47. Bloemen OJN, de Koning MB, Schmitz N, et al. White-matter markers for psychosis in a prospective ultra-high-risk cohort. Psychol Med. 2010;40(8):1297-304.
48. Walterfang M, Yung A, Wood AG, et al. Corpus callosum shape alterations in individuals prior to the onset of psychosis. Schizophr Res. 2008;103(1-3):1-10.
49. Farooq S, Large M, Nielssen O, Waheed W. The relationship between the duration of untreated psychosis and outcome in lowand- middle income countries: a systematic review and meta analysis. Schizophr Res. 2009;109(1-3):15-23.
50. Jeppesen P, Petersen L, Thorup A, et al. The association between premorbid adjustment, duration of untreated psychosis and outcome in first-episode psychosis. Psychol Med. 2008;38(8):1157-66. (Pubitemid 351950154)
51. Takahashi T, Suzuki M, Tanino R, et al. Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report. Psychiatry Res. 2007;154(3):209-19. (Pubitemid 46428523)
52. Malla AK, Bodnar M, Joober R, Lepage M. Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first episode psychosis. Schizophr Res. 2011;125 (1):13-20.
53. Wobrock T, Gruber O, Schneider-Axmann T, et al. Internal capsule size associated with outcome in first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2009;259(5):278-83.
54. Boonstra G, Cahn W, Schnack HG, et al. Duration of untreated illness in schizophrenia is not associated with 5-year brain volume change. Schizophr Res. 2011;132(1):84-90.
55. Lieberman J, Chakos M, Wu H, et al. Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry. 2001;49(6):487-99. (Pubitemid 32226407)
56. Milev P, Ho B-C, Arndt S, et al. Initial magnetic resonance imaging volumetric brain measurements and outcome in schizophrenia: a prospective longitudinal study with 5-year follow-up. Biol Psychiatry. 2003;54(6):608-15. (Pubitemid 41115097)
57. van Haren NEM, Cahn W, Hulshoff Pol HE, et al. Brain volumes as predictor of outcome in recent-onset schizophrenia: a multicenter MRI study. Schizophr Res. 2003;64(1):41-52. (Pubitemid 37153348)
58. Cahn W, van Haren NEM, Hulshoff Pol HE, et al. Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. Br J Psychiatry. 2006;189:381-2. (Pubitemid 44606754)
59. KemptonMJ, Stahl D,Williams SCR, DeLisi LE. Progressive lateral ventricular enlargement in schizophrenia: A meta-analysis of longitudinal MRI studies. Schizophr Res. 2010;120(1-3):54-62.
60. Ho B-C, Andreasen NC, Nopoulos P, et al. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry. 2003;60(6):585-94. (Pubitemid 36682316)
61. Nakamura M, Salisbury DF, Hirayasu Y, et al. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol Psychiatry. 2007;62(7):773-83. (Pubitemid 47374652)
62. Mitelman SA, Canfield EL, Brickman AM, et al. Progressive ventricular expansion in chronic poor-outcome schizophrenia. Cogn Behav Neurol. 2010;23(2):85-8.
63. Wood SJ, Berger GE, Lambert M, et al. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry. 2006;63 (9):969-76. (Pubitemid 44330455)
64. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 2001;58(2):148-57. (Pubitemid 32142752)
65. Takahashi T, Wood SJ, Yung AR, et al. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch Gen Psychiatry. 2009;66(4):366-76.
66. van Haren NEM, Hulshoff Pol HE, Schnack HG, et al. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry. 2008;63(1):106-13. (Pubitemid 350234880)
67. Kasai K, Shenton ME, Salisbury DF, et al. Progressive Decrease of Left Superior Temporal Gyrus Gray Matter Volume in Patients With First-Episode Schizophrenia. Am J Psychiatry. 2003;160(1):156-64. (Pubitemid 36042440)
68. Greenstein DK, Wolfe S, Gochman P, et al. Remission Status and Cortical Thickness in Childhood-Onset Schizophrenia. J Am Acad Child Adolesc Psychiatry. 2008;47(10):1133-40.
69. Thompson PM, Vidal C, Giedd JN, et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA. 2001;98 (20):11650-5. (Pubitemid 32928783)
70. Kubicki M, McCarley R, Westin C-F, et al. A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res. 2007;41 (1-2):15-30. (Pubitemid 44780754)
71. Sommer IE, Clos M, Meijering AL, et al. Resting state functional connectivity in patients with chronic hallucinations. PLoS One. 2012;7(9):e43516.
72. Vercammen A, Knegtering H, den Boer JA, et al. Auditory hallucinations in schizophrenia are associated with reduced functional connectivity of the temporo-parietal area. Biol Psychiatry. 2010;67(10):912-8.
73. Plaze M, Paillère-Martinot M-L, Penttilä J, et al. "Where do auditory hallucinations come from?"-a brain morphometry study of schizophrenia patients with inner or outer space hallucinations. Schizophr Bull. 2011;37(1):212-21.
74. Arango C, Rapado-Castro M, Reig S, et al. Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry. 2012;69(1):16-26.
75. Prasad KMR, Sahni SD, Rohm BR, Keshavan MS. Dorsolateral prefrontal cortex morphology and short-term outcome in firstepisode schizophrenia. Psychiatry Res. 2005;140(2):147-55. (Pubitemid 41540426)
76. Sigmundsson T, Maier M, Toone BK, et al. Frontal lobe Nacetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res. 2003;64(1):63-71. 78. (Pubitemid 37153350)
77. Bodnar M, Achim AM, Malla AK, et al. Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia. Br J Psychiatry. 2012;200(4):300-7.
78. van Veelen NMJ, Vink M, Ramsey NF, et al. Prefrontal lobe dysfunction predicts treatment response in medication-naive firstepisode schizophrenia. Schizophr Res. 2011;129(2-3):156-62.
79. Bodnar M, Malla AK, Czechowska Y, et al. Neural markers of remission in first-episode schizophrenia: a volumetric neuroimaging study of the hippocampus and amygdala. Schizophr Res. 2010;122(1-3):72-80.
80. Leifker FR, Bowie CR, Harvey PD. Determinants of everyday outcome in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr Res. 2009;115 (1):82-7.
81. Winterer G, Coppola R, Goldberg TE, et al. Prefrontal broadband noise, working memory, and genetic risk for schizophrenia. Am J Psychiatry. 2004;161(3):490-500. (Pubitemid 38326104)
82. Roffman JL, Weiss AP, Deckersbach T, et al. Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(6):990-5.
83. Karnik-Henry MS, Wang L, Barch DM, et al. Medial temporal lobe structure and cognition in individuals with schizophrenia and in their non-psychotic siblings. Schizophr Res. 2012;138(2- 3):128-35.
84. Morey RA, Mitchell TV, Inan S, et al. Neural correlates of automatic and controlled auditory processing in schizophrenia. J Neuropsychiatry Clin Neurosci. 2008;20(4):419-30.
85. Ziauddeen H, Murray GK. The relevance of reward pathways for schizophrenia. Curr Opin Psychiatry. 2010;23(2):91-6.
86. Nielsen MO, Rostrup E, Wulff S, et al. Alterations of the brain reward system in antipsychotic naïve schizophrenia patients. Biol Psychiatry. 2012;71(10):898-905.
87. Mamah D, Wang L, Barch D, et al. Structural analysis of the basal ganglia in schizophrenia. Schizophr Res. 2007;89(1-3):59-71. (Pubitemid 44881297)
88. Achim AM, Bertrand M-C, Sutton H, et al. Selective abnormal modulation of hippocampal activity during memory formation in first-episode psychosis. Arch Gen Psychiatry. 2007;64(9):999-1014. (Pubitemid 47360845)
89. Takahashi H, Koeda M, Oda K, et al. An fMRI study of differential neural response to affective pictures in schizophrenia. Neuro- Image. 2004;22(3):1247-54. (Pubitemid 38829213)
90. Brunet-Gouet E, Decety J. Social brain dysfunctions in schizophrenia: a review of neuroimaging studies. Psychiatry Res. 2006;148(2-3):75-92. (Pubitemid 44750585)
91. Delvecchio G, Sugranyes G, Frangou S. Evidence of diagnostic specificity in the neural correlates of facial affect processing in bipolar disorder and schizophrenia: a meta-analysis of functional imaging studies. Psychol Med. 2012;9:1-17.
92. Quincozes-Santos A, Bobermin LD, Tonial RPL, et al. Effects of atypical (risperidone) and typical (haloperidol) antipsychotic agents on astroglial functions. Eur Arch Psychiatry Clin Neurosci. 2010;260(6):475-81.
93. Gassó P, Mas S, Molina O, et al. Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells. Prog Neuropsychopharmacol Biol Psychiatry. 2012;36(1):71-7.
94. Navari S, Dazzan P. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol Med. 2009;39(11):1763-77.
95. Bor J, Brunelin J, d' Amato T, et al. How can cognitive remediation therapy modulate brain activations in schizophrenia? An fMRI study Psychiatry Res. 2011;192(3):160-6.
96. Eack SM, Hogarty GE, Cho RY, et al. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry. 2010;67(7):674-82.